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SUMMARY
To describe the epidemiologic profile and prevalence of cardiopathy in 163 Trypanosoma cruzi serum positive blood donor
candidates, a descriptive study was carried out between August, 1996 and November, 1997 at the Londrina State University
Chagas Disease Outpatient Clinic. The profile found was: young, average age 42.95 ± 8.62 years; male (65%); Caucasian (84%);
low level of schooling; low family income; agricultural worker (26%); born in the state of Paraná (67%); from rural areas (85%);
migrated to the city (85%); and the vector as the main mechanism of transmission. During the clinical characterization a chronic
cardiac form was found in 38% of the patients and classified as cardiac suggestive form in 21% and little suggestive of Chagas
disease in 17%. No significant difference was found among age group distribution, sex and the presence of cardiac symptoms in
patients with or without cardiopathy. This study emphasizes the importance of expanding medical services to areas with a greater
prevalence of infected individuals, in a hierarchical manner and aiming at decentralization.
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INTRODUCTION
Chagas disease is a parasitosis caused by the protozoan
Trypanosoma cruzi. It is endemic in the Americas, from central Mexico
to the south of Argentina and Chile12,34. It is estimated that the number
of infected individuals in Brazil is around three million and it is one of
the greatest public health problems in the Country1,13.
Means to control the main route of transmission - vectorial - have
been available since the 40s, following the proven effectiveness of
treatment with insecticides to eliminate the vector in a direct way or
indirectly through improvement of living conditions in rural areas34.
Prior selection of blood donors through serologic screening is the main
strategy to prevent transfusion transmission - the second most important
path of transmission - which was introduced as a health policy in Brazil
in 19692. However, with the emergence of acquired immunodeficiency
virus infections, a complete review of the policy for blood and
hemoderivates was carried out in Brazil. The Ministry of Health
recommended that blood from all donors should be tested for anti-
Trypanosoma cruzi antibodies using at least two serologic techniques2,36.
With these measures, control by the hemotherapy services has been
elevated to over 80% throughout Brazil and the median of infected
donor candidates is below 0.8%14. In Paraná, the effectiveness of these
measures was demonstrated from 1985, when an analysis of 1,977
blood donor candidates from 33 cities of the state showed a
seropositivity of 7.2%29. Furthermore, according to the Coordination
of Blood and Hemoderivates of the Ministry of Health this figure for
the state as whole had decreased to 0.86% in 19956. In the city of
Londrina, data collection carried out by various authors in the years of
1958, 1975, 1996 and 1998, found a decreasing seroprevalence of
6.92%, 7.49%, 1.4% and 1.3%, respectively4,5,31,32.
Nowadays, with the main way of transmission under control, the
principal concern is regarding assistance to infected individuals,
particularly their situation in the job market, the social services
involved and the necessity for adequate medical care18. The assistance
to rejected donors referred by hemotherapy services is a special
concern. These donors present peculiarities such as the presence of
inconclusive serologic screening, or a confirmed diagnosis in
apparently healthy individuals, that might or might not have clinical
implications - of which cardiopathy is the most frequent15,16,19. It is
not the responsibility of hemotherapy services to clinically attend
these patients; therefore there is a need to provide related care services
in various centers23.
Faced with a previous study that affirmed that 80% of infected
patients could receive medical care in primary care services18, a clinical
epidemiologic study in a sample of our population was proposed. The
aim of this study was to set goals for the improvement of such services
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and to assess the possibility of decentralization, through determination
of the patients‘ characteristics.
MATERIAL AND METHODS
Design: A descriptive study carried out through the review of
medical records and dossiers of 163 blood donor candidates that
presented positive serologic reaction to Trypanosoma cruzi, referred
by hemotherapy services and attended at the Londrina State University
Chagas Disease Outpatient Clinic from August 1996 to November 1997.
Data collection and mensuration
Personal data: Hospital record, age, gender, race, educational level,
monthly family income, profession, origin and present residency,
classified by state of origin. The State of Paraná was divided into
geographic micro and meso regions, according to the Brazilian Institute
of Geography and Statistics20.
Epidemiologic data: The way of infection transmission was
evaluated by knowledge of the vector, residency or travel in endemic
areas, mother or other family member with Chagas disease and history
of blood transfusion. The patients were also asked whether they had
effectively donated blood prior to the present diagnosis of T. cruzi
infection.
 
Serologic diagnosis: Carried out through indirect
immunofluorescence techniques9 (LIOSERUM, São Paulo, Brazil and
LABORCLIN, Paraná, Brazil); indirect hemagglutination21,26 (EBRAM,
São Paulo, Brazil) and immunoenzymatic assay35 (ABBOTT, São Paulo,
Brazil). The individuals that presented at least two positive reactions
were considered infected.
Clinical data: Patients that complained of at least one of the
following were considered symptomatic: dyspnea, palpitations,
precordialgia, fainting and/or dizziness. All patients were submitted
to conventional electrocardiogram in 12 derivations with long D2 (EKG)
and thorax radiography at posteroanterior incidence. EKG with
alterations characteristic of Chagas disease were considered to be those
that revealed the presence of: complete right bundle branch block, left
anterior hemiblock, A-V block, multifocal ventricular extrasystoles
and sinusal bradycardia connected to ventricular repolarization
alteration or to other alterations, according to the method used by the
National Electrocardiographic Survey on Chagas Disease24. To evaluate
the presence of cardiomegaly, analysis of the cardiothoracic index
(I:CT) was used in thorax radiography, considered indicator of
cardiomegaly when greater than 50%. The cardiac form was defined
by the presence of electrocardiographic alterations and/or cardiomegaly
in the thorax radiography. The cardiac form was classified as suggestive
of Chagas disease when characteristic electrocardiographic alterations
were present, and little suggestive of Chagas disease when other
electrocardiographic alterations were identified.
Statistical analysis: The data was stored in the software Epi Info
release 6.04 and analyzed with SAS software - Statistical Analysis
System release 6.11. In the analysis, descriptive statistics were used
and Chi-square test applied to compare proportions. Statistical
significance was set at the 5% level.
RESULTS
Age varied from 18 to 63 years, with a mean of 42.5 and standard
deviation of 8.62 years. It was observed that 46% of the patients were
in the 40-50 y age group. Most of the patients were male - 106 (65%),
white - 137 (84%), illiterate - 23 (14%) or with incomplete basic
education - 109 (67%) and with monthly family income up to three
minimum wages - 134 (82%). Agriculture was the professional area
most referred to, followed by self-employed, identified in 42 (26%)
and 31 (19%) patients, respectively. Most of the patients were born in
the state of Paraná - 108 (66%), followed by Minas Gerais - 23 (14%),
São Paulo - 20 (12.5%) and other states - 12 (7.5%). It was observed
that 138 (85%) patients came from rural areas. In the evaluation of the
origin of 108 patients from the state of Paraná, 91 (84%) come from
the North Pioneer mesoregion, mainly from the microregions of
Wenceslay Braz - 41 (38%), Assaí - 22 (20%) and Cornélio Procópio -
20 (18.5%). Only 6 (5.5%) come from the microregion of Londrina.
All 163 patients currently reside in the state of Paraná, the majority in
the urban area - 138 (85%), proportionally distributed among the North
Pioneer - 82 (50.4%) and North Central - 80 (49%) mesoregions, with
predominance of the microregion of Londrina - 64 (39%), followed by
Wenceslay Braz - 44 (27%).
Regarding the presence of symptoms, it was observed that 98 (60%)
patients presented symptoms and 65 (40%) were asymptomatic. In the
EKG analysis, 107 (65%) did not present alteration. Out of 56 (34.5%)
patients with electrocardiographic alterations (Table 1), 29 (18%)
presented alterations considered characteristic of Chagas disease and
27 (16.5%) presented other alterations. It was observed that 145 (89%)
patients presented normal cardiac area and 18 (11%) presented
cardiomegaly in the thorax radiography. Analysis of the
Table 1
Distribution of the electrocardiographic alterations in 56 of the
163 patients studied
Alterations in electrocardiogram No. %
VRA 17 30.0
SB 8 14.0




CRBB, LAH and VRA 2 3.5
SB and LAH 2 3.5
LAH and VRA 2 3.5
1° AVB 1 2.0
2° AVB 1 2.0
1° AVB, LAH and VRA 1 2.0
2° AVB, LAH and CRBB 1 2.0
SB and CRBB 1 2.0
SB and VE 1 2.0
TOTAL 56 100.0
CRBB: complete right bundle branch block; LAH: left anterior hemiblock; 1°
AVB: 1st atrioventricular block; 2° AVB: 2nd atrioventricular block; SB: sinusal
bradycardia; VE: ventricular extrasystoles; VRA: ventricular repolarization
alteration.
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electrocardiogram and thorax radiography for clinical characterization
showed that 62 (38%) patients presented electrocardiographic and/or
radiologic alterations, which characterized the presence of the cardiac
form. Out of these, 35 (21%) were characterized as suggestive of cardiac
form and 27 (16.5%) as cardiac form little suggestive of Chagas disease
(Fig. 1).
When comparing the clinical forms of Chagas disease according
to age group, the chronic cardiac form was less frequent in individuals
under 30 years of age (2%), despite the fact that a proportional
distribution of clinical forms in different age groups was observed (p
= 0.210) (Fig. 2). It was also observed that, when comparing the clinical
form and gender, the chronic cardiac form was present in 19/57 (33%)
female patients and in 43/106 (41%) male patients. The results were
not statistically significant (p = 0.364) (Fig. 3). When the clinical form
of Chagas disease was compared to the presence of symptoms, it was
evident that in patients with chronic cardiac form, 45% presented
symptoms and 55% presented no symptoms. In those patients with
chronic non-cardiac form, 37% presented symptoms and 63% presented
no symptoms. When comparing these distributions, statistical
significance was not observed (p = 0.280) (Fig. 4).
DISCUSSION
About one hundred years after its description, Chagas disease
remains a serious public health problem. Its epidemiologic and clinical
aspects have been emphasized and continue to be of great value for the
planning of prophylactic actions - seen as a great weapon against this
infection12.
The epidemiologic profile of the blood donor candidate infected
by Trypanosoma cruzi revealed a young, male and white individual
with a low level of education. These results were similar to those
published by GONTIJO et al. (1996), with the exception of race, as
Fig. 1 - Distribution of the 163 studied patients, in accordance with the clinical form of
Chagas disease.
Fig. 2 - Percentage distribution of the patients according to age and clinical form of Chagas
disease.
Fig. 3 - Percentage distribution of the patients according to gender and clinical form of
Chagas disease.
Fig. 4 - Percentage distribution of the patients according to the presence of symptoms and
clinical form of Chagas disease.
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the author found a predominance of mulatto or black patients (60%).
This difference may be explained by regional variations in racial
distribution. According to GUARIENTO et al. (1996), the
predominance of males is explained by cultural differences in the
practice of blood donation that attributes male individuals the role of
donor par excellence.
Other identified aspects were the prevalence of low monthly family
income and agriculture as the professional area. Previous observations
had already revealed that the Chagas patient is generally an individual
with low professional qualification and incomplete education, who
works in functions that require greater physical effort and that do not
offer adequate conditions of remuneration16.
Regarding origin, the majority was born in the rural area (85%),
coming from the state of Paraná - 108 (66%), followed by 23 (14%)
from Minas Gerais, 23 (14%) from São Paulo and 12 (7.5%) from
other states. Of 108 patients from the state of Paraná, the majority
(84%) came from the North Pioneer mesoregion. These characteristics
are related to aspects of colonization and development of the regions
considered endemic in the State, since, from the XIX Century on, the
north region has differed from the other regions due to the development
of coffee culture, started by migrants from the states of Minas Gerais
and São Paulo7.
The migrating component was evident in this study, especially
regarding rural-urban migration, since, when the present home was
analyzed, all patients lived in the state of Paraná and the majority (85%)
in an urban area. These results are connected to the regional transformations
that occurred within the state, mainly following changes in agricultural
production. From 1960 on, coffee plantations began to be replaced by
other mechanized cultures such as soy and wheat, which led to migration
to cities that required a larger labor force due to the industrialization
process8. This intense rural-urban migratory process was also observed in
studies carried out with Chagas patients in other regions of the Country
such as the state of São Paulo and Minas Gerais3,17,18.
Most of the patients (142/87%) evaluated in this study were from
regions endemic for Chagas disease and born in a rural area. This fact
suggests that the predominant mechanism of transmission was vectorial.
Out of the remaining 21 patients, 10 (6%) had a history of transfusion
of blood or hemoderivates, characterizing the possibility of transfusion
transmission and 6 (4%) were children of mothers with positive serology
for Chagas disease, a fact suggesting the possibility of congenital
transmission. Five (3%) patients were born and always resident in an
urban area and denied a previous history of blood transfusion or mother
with positive serology for Chagas disease, consequently it was
impossible to characterize the transmission mechanism.
From 163 patients, 39 (24%) reported having already donated blood,
out of which 14 (34%) referred to negative result of previous serology.
Some authors have already demonstrated the possibility of false negative
results of serologic reactions to the diagnosis of Trypanosoma cruzi
infection in proven infected individuals, mainly when techniques with
low sensitivity and specificity were used, such as the complement
fixation reaction10.
Electrocardiographic alterations were presented by 56/163 (34%)
individuals although in only 29 (18%) patients the electrocardiographic
wave detected alterations considered characteristic of Chagas
cardiopathy. According to MACÊDO (1993), in the National
Electrocardiographic Survey to evaluate the prevalence of Chagas
cardiopathy, the prevalence of electrocardiographic alterations in
individuals seropositive for Trypanosoma cruzi infection was initially
of 37.4%, but fell 24.4%, when only the alterations characteristic of
Chagas cardiopathy were considered. In the state of Paraná, the same
survey detected that 23% of the seropositive patients presented
electrocardiographic alterations characteristics of Chagas cardiopathy.
When the electrocardiographic and radiologic alterations are
analyzed as a whole, in 35 (21%) patients, the presence of characteristic
electrocardiographic alterations and/or the presence of cardiomegaly
in the thorax radiography characterizing the cardiac form suggestive
of Chagas disease was observed; in 27 (17%) patients, non-
characteristic electrocardiographic alterations were observed,
characterizing a cardiac form little suggestive of Chagas disease. When
considering all the electrocardiographic and radiologic alterations
detected, the prevalence of Chagas cardiopathy was 38% (62 patients).
Studies carried out on samples of blood donor candidates seropositive
for Trypanosoma cruzi infection have detected prevalence of Chagas
cardiopathy between 30.0 and 56.7%10,18,22,27,33. This variation may be
related to a lack of standardization of the adapted criteria in
electrocardiographic analysis or to regional variations in the prevalence
of this infection.
The analysis of the clinical form of patients evaluated in the present
study revealed that 65 (40%) were symptomatic; the most frequent
reported symptom was dyspnea in 45 (28%), followed by palpitation
in 34 (21%), dizziness in 26 (16%), precordialgia in 24 (15%) and
fainting in 6 (4%). When comparing the patients with Chagas
cardiopathy to those without this illness, regarding the presence of
symptoms, it was verified that there was no statistically significant
difference between both groups. According to MARIN-NETO, SIMÕES
& SARABANDA (1997), the natural history of Chagas disease is
prodigal in phases and clinical forms and there is flagrant dissociation
between the presence of symptoms and objective signs of organic
damage.
The evaluation according to age showed that there was a greater
frequency of cardiopathy in patients who were 40 years old and older,
however, without statistical significance. According to PRATA et al.
(1993), the greater frequency of electrocardiographic alterations in the
elderly may be related to longer time evolution of the Chagas
cardiopathy and to the concomitance of other affections such as systolic
arterial hypertension and coronary insufficiency. This difference was
probably not detected statistically in our study due to the sample size.
According to PEREIRA-BARRETTO et al. (1993), the prevalence
of Chagas cardiopathy is greater and the prognosis worse in male
patients seropositive for Trypanosoma cruzi infection. No difference
was found regarding the prevalence of cardiopathy and gender in our
study.
In view of the present results and according to the principle that
attendance of Chagas patients should take place preferentially close to
where they live, we concluded that human resources training and
OLIVEIRA-MARQUES, D.S.; BONAMETTI, A.M.; MATSUO, T. & GREGORI JUNIOR, F. - The epidemiologic profile and prevalence of cardiopathy in Trypanosoma cruzi infected blood
donor candidates, Londrina, Paraná, Brazil. Rev. Inst. Med. trop. S. Paulo, 47(6):321-326, 2005.
325
qualification are necessary, along with the organization of services
with diagnostic support to provide good quality serology and basic
complementary exams such as electrocardiogram and thorax
radiography. These should be provided in health services already
existent in the regions with great occurrence of infected individuals
requiring assistance at primary level. Since interinstitutional integration
is a basic characteristic in the operationalization of the model of health
care in Chagas disease, the maintenance of a Service at the Londrina
State University Clinics Hospital is necessary, to serve as a reference
center for patients who need specialized care.
RESUMO
Perfil epidemiológico e prevalência de cardiopatia em candidatos
a doador de sangue infectados por Trypanosoma cruzi, Londrina,
Paraná, Brasil
Objetivando-se traçar o perfil epidemiológico e a prevalência de
cardiopatia, realizou-se estudo descritivo em 163 candidatos a doador
de sangue infectados por Trypanosoma cruzi, atendidos no período de
agosto de 1996 a novembro de 1997 no ambulatório de doença de
Chagas do Hospital de Clínicas da Universidade Estadual de Londrina.
O perfil epidemiológico foi de paciente jovem, média de idade de 42,95
± 8,62 anos, sexo masculino (65%), raça branca (84%), baixa
escolaridade, baixa renda familiar, agricultor (26%), natural do estado
do Paraná (67%), de zona rural (85%), residindo atualmente em zona
urbana (85%), sendo o vetorial o principal mecanismo de transmissão.
A forma crônica cardíaca, encontrada em 38% foi classificada em forma
cardíaca sugestiva de doença de Chagas em 21% e pouco sugestiva em
17% dos pacientes. Não houve diferença significativa na distribuição
da faixa etária, sexo e presença de sintomas cardíacos em relação aos
pacientes com ou sem cardiopatia. O estudo ressalta a importância da
expansão de serviços de atendimento em regiões de maior ocorrência
de indivíduos infectados e manutenção de serviços de referência, para
oferecer atendimento de forma descentralizada e hierarquizada.
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